Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Digital content for Acrivon Therapeutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Acrivon Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Watertown, MA, USA 480 Arsenal Way Suite 100 Watertown, MA 02472
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-reports-initial-positive-clinical-data-acr

PRESS RELEASE
24 Apr 2024

https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-host-corporate-rd-event-highlighting-ap3

PRESS RELEASE
16 Apr 2024

https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-presents-data-aacr-annual-meeting

PRESS RELEASE
10 Apr 2024

https://ir.acrivon.com/news-releases/news-release-details/acrivon-therapeutics-announces-130-million-private-placement

PRESS RELAESE
09 Apr 2024

https://www.biopharmadive.com/news/acrivon-ipo-file-biotech-cancer-lilly/634468/

BIOPHARMADIVE
19 Oct 2022

https://www.globenewswire.com/news-release/2022/06/28/2470336/0/en/Akoya-Biosciences-to-Partner-with-Acrivon-Therapeutics-for-the-Clinical-Development-of-Acrivon-s-Proprietary-OncoSignature-Test-into-a-Companion-Diagnostic.html

GLOBENEWSWIRE
28 Jun 2022

https://www.fiercebiotech.com/biotech/acrivon-therapeutics-secures-100m-to-give-eli-lilly-cancer-drug-another-try-fund-2-solid

K. LaHucik FIERCEBIOTECH
12 Nov 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY